RCB1229

Risk Reward, Plenty of Potential vs Problems

Pembelian
NASDAQ:MYGN   Myriad Genetics, Inc.
MYGN has been a player for a while, large company, with actual earnings, however litigation and companies are generally a bad thing. "healthy" enough of a chart for me to participate, but I will not have much patience to the downside, stop in place.

**Long this last collapse, limited in size... confidence is enough to buy, not enough to bet the farm
Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.